Skip to main content

Boehringer Ingelheim Pharmaceuticals opens call for early-stage innovators pursuing therapeutic research

To celebrate the spirit of innovation, Boehringer Ingelheim Pharmaceuticals, Inc. will be awarding an Innovation Prize in NYC on August 15 this year! Please submit your entry by July 19 for a chance to win!

The Prize:

·         One Golden Ticket (pre-paid rent for one reserved lab bench at BioLabs@NYULangone in NYC for 1 year; valued at $75,000)

Entry Deadline:

·         July 19

Date of Competition:

·         August 15 (5-8pm) – Register for the event here


·         Early-stage innovators and spin-outs that are pursuing life-science therapeutic platform technologies and therapeutics (in any indication, any modality) are invited to participate. Diagnostics, Instrument development, and Health-IT are excluded at this time.

·         Companies must be founded and have their principal place of business in New York

·         Companies must not have a major partnership with another large bio-pharmaceutical company

·         Companies must be focused on new target concepts or drug discovery.

How to Apply:

·         Applicants must provide a non-confidential deck of no more than ten slides. Slides must address unmet medical need, solution, scientific principle, key data supporting the scientific principle, overview of business case, and intellectual property

·         Please submit proposals through the BI Portal or to Monica Cheng (

Shortlisted applicants will be invited to present their ideas in a poster session at BioLabs, NYC, on August 15, 2019, from which a final short-list is selected to pitch their ideas to a panel of judges.  Winner will be announced during at the end of the event on August 15.